1. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer 
Inbar Nardi-Agmon, MD, Manal Abud-Hawa, MSc, Ori Liran, MSc, Naomi Gai-Mor, MSc, Maya Ilouze, PhD, Amir Onn, MD, Jair Bar, MD, PhD, Dekel Shlomi, MD, Hossam Haick, PhD, Nir Peled, MD, PhD 
Journal of Thoracic Oncology 
Volume 11, Issue 6, Pages (June 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Graphic representation of breath sampling and analysis procedure. (A) Collection of the breath sample in a single-step process into a chemically inert Mylar bag; (B) transfer of the bag's contents to Tenax sorbent tube; (C) thermal desorption to release the volatile organic compounds from the sorbent tube; (D) gas chromatography/mass spectrometry (GC-MS) to detect and analyze the compounds; and (E) sensor array containing gold nanoparticles with different modifications and polycyclic aromatic hydrocarbons.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Hot-plot for the follow-up of lung cancer states. Patients are represented by the rows, and columns give successive breath samples for each patient. The scale represents the normalized resistance of the sensor, as described before, and units are given in ohms. Samples not identified by the sensor are marked by black blocks. The red tones in the color scale represent increased resistance of the sensor, indicating a worsening of the disease, whereas the green tones represent a decrease in resistance of the sensor and indicate a positive response to treatment. PD, progressive disease; PR, partial response; SD, stable disease.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4. Figure 3
Selected example of consecutive CT scans for patient 17 in the study (73 years old with SCLC), with the corresponding breath samples and NA-NOSE sensor's resistance (given in ohm). ∗Before initiation of treatment. CT, computerized tomography; SCLC, small cell lung cancer; NA-NOSE, chemical nanoarray; PD, progressive disease; PR, partial response.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions